$IMNM
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Healthcare
Sector
Biotechnology
Industry
Clay Siegall
CEO
131
Employees
$25.69
Current Price
$2.03B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 2 | $940,453.28 | 36,088 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 3 | $3,214,008.72 | 126,704 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 3 | $3,214,008.72 | 126,704 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 4 | 15 | $13,476,647.18 | 598,846 | ||
| 3 months | Buys | 1 | 4 | $307,760.00 | 15,500 | 1:44.45 |
| Sells | 5 | 17 | $13,680,467.18 | 609,346 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: